(Q43663440)

English

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration (English)

1 reference

Europe PubMed Central

25 November 2017

anorexia nervosa

0 references

0 references

1

1 reference

Europe PubMed Central

25 November 2017

author name string

Kaye WH

2

1 reference

Europe PubMed Central

25 November 2017

Weltzin TE

3

1 reference

Europe PubMed Central

25 November 2017

Perel J

4

1 reference

Europe PubMed Central

25 November 2017

Moss H

5

1 reference

Europe PubMed Central

25 November 2017

McConaha C

6

1 reference

Europe PubMed Central

25 November 2017

Pollice C

7

1 reference

Europe PubMed Central

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

25 November 2017

International Journal of Eating Disorders

1 reference

Europe PubMed Central

25 November 2017

30

1 reference

Europe PubMed Central

25 November 2017

1

1 reference

Europe PubMed Central

25 November 2017

57-68

1 reference

Europe PubMed Central

25 November 2017

Serotonin and appetite

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Personality features of women with good outcome from restricting anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Lithium in Tricyclic-Resistant Depression Correlation of Increased Brain 5-HT Function with Clinical Outcome

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Effects of ovarian hormones on norepinephrine and dopamine turnover in individual hypothalamic and extrahypothalamic nuclei

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. II. Validity

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonergic systems

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonergic Function in Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Acute effects of estradiol on circulating luteinizing hormone and prolactin concentrations and on serotonin turnover in individual brain nuclei.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

The clinical utility of pharmacological agents that act at serotonin receptors

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Estrogen-serotonin interactions: implications for affective regulation.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

5-HT2C receptor activation decreases appetite and body weight in obese subjects

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonergic control of the organization of feeding and satiety

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

A Homologous Radioimmunoassay for Human Prolactin1

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Abnormal caloric requirements for weight maintenance in patients with anorexia and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Studies of serotonin function in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Patients with anorexia nervosa have elevated scores on the Yale-Brown obsessive-compulsive scale

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge.

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

CSF 5-HIAA and suicide in non-depressed schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Eating disorders: progress and problems

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

21 January 2018

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1002%2FEAT.1054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EAT.1054

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43663440&oldid=2102380273"